| original | translation |
|----------|-------------|
| This has been bugging me for years now, and I thought one of you fine people would know - in Eclipse's .classpath files, what is the combineaccessrules attribute of the classpathentry element actually used for?<br/><br/>I can see in the Java Build Path config dialog that it can be maniuplated, but I can't think of a good use case for it. If I muck about with the settings, or modify the .classpath file manually, it doesn't seem to have any effect.<br/><br/>I'm hoping someone else has put it to good use, and I can steal their ideas. Basically, it's an itch I'm trying to scratch.<br/><br/>3 Answers<br/><br/>With proper use of access rules you can prevent using "internal" and/or "non-api" classes and methods. When you add a class or package as Forbidden or Discouraged the compiler show an error or warning when you use that class or class from the specified package. For a longer introduction of access rules you should read this short article.<br/><br/>For using combine access rules imagine the following situation:<br/><br/>You have 2 projects, A and B.<br/><br/>On the classpath of project A there is a jar file that is exported. The jar contains some "stable api", "unstable api" and "non-api" public classes.<br/><br/>Project B depends on project A.<br/><br/>You do not allow using "non-api" classes in project A so you set some Forbidden access rules on those classes / packages.<br/><br/>In project B you do not allow using "non-api" as well, but you do want to get a warning when using "unstable api". In this case in project B you only have to set the additional Discouraged access rules if you check the Combine rules with the access rules of the exported project entries.<br/><br/>Access rules are handy little things, but dangerous. They exclude a source file from the project compiler but leave the file intact in the filesystem.<br/><br/>The project I work on has a bootstrap class in one of our source folders, but if we include the entire folder the project classpath it won't compile (it's a long story and the build process handles this).<br/><br/>So we use an eclipse access rule to exclude it and it never bothers us during development. This means we can't easily change the code, but it's one of those classes that literally hasn't been touched in years.<br/><br/>Combine Access Rules, judging by the JavaDoc, is a real edge use case. To use it you would have to have:<br/><br/>an access rule in an exported source entry of one project<br/><br/>a link to that project from a parent project<br/><br/>a need to combine the access rules of the sub project with the parent<br/><br/>I really can't say how it would be useful, but I hope that at least answers your "what is it" question :) | Tá sé seo ag cur mo chuid Gaeilge ar feadh na mblianta anois, agus shíl mé go mbeadh a fhios ag duine agaibh - i gcomhaid. i ngach ceann de na scannáin Ghaeilge, cad é an tréith comh-rochtana den ghné ranga a úsáidtear i ndáiríre?<br/><br/>Is féidir liom a fheiceáil sa dialóg figation Java Build Path gur féidir é a ionramháil, ach ní féidir liom smaoineamh ar chás úsáide maith dó.Má tá mé ag magadh faoi leis na socruithe, nó an comhad.classpath a mhodhnú de láimh, ní cosúil go bhfuil aon éifeacht aige.<br/><br/>Tá mé ag súil go bhfuil duine eile é a chur ar úsáid mhaith, agus is féidir liom a ghoid a gcuid smaointe. Go bunúsach, tá sé ar itch Tá mé ag iarraidh a scratch.<br/><br/>3 Freagraí<br/><br/>Agus úsáid cheart á baint agat as rialacha rochtana, is féidir leat cosc a chur ar ranganna agus modhanna "inmheána" agus/nó "neamh-api" a úsáid. Nuair a chuireann tú rang nó pacáiste le Cosc nó le Nochtadh, léiríonn an tiomsaitheoir earráid nó rabhadh nuair a úsáideann tú an rang nó an rang sin ón bpacáiste sonraithe.Chun na rialacha rochtana a thabhairt isteach níos faide ba cheart duit an t-alt gearr seo a léamh.<br/><br/>Le haghaidh úsáid a bhaint as rialacha rochtana le chéile, a shamhlú an staid seo a leanas:<br/><br/>Tá tú 2 tionscadal, A agus B.<br/><br/>Ar an ardán tionscadail A tá comhad jar a onnmhairítear.Tá roinnt "api cobhsaí", "appi éagobhsaí" agus "neamh-api" ranganna poiblí sa publicjobs.com.<br/><br/>Braitheann tionscadal B ar thionscadal A.<br/><br/>Ní cheadaíonn tú ranganna "neamh-api" a úsáid sa tionscadal Mar sin, shocraigh tú roinnt rialacha maidir le rochtain toirmiscthe ar na ranganna / pacáistí sin.<br/><br/>I dtionscadal B nach bhfuil tú ar chumas ag baint úsáide as "neamh-api" chomh maith, ach ba mhaith leat a fháil rabhadh nuair a úsáid a bhaint as "Api éagobhsaí". Sa chás seo sa tionscadal B, ní gá duit ach na rialacha breise maidir le rochtain a shocrú Díchur má sheiceálann tú na rialacha Comh-Aireachta le rialacha rochtana iontrála an tionscadail arna n-onnmhairiú.<br/><br/>Tá rialacha rochtana an-mhaith rudaí beag, ach contúirteach. eisiamh siad comhad foinse ón t-iomaitheoir tionscadail ach fág an comhad slán sa chóras comhaid.<br/><br/>Tá rang tosaithe ag an tionscadal a oibreoidh mé i gceann dár bhfillteán foinse, ach má chuimsítear an fillteán tionscadail ar fad nach dtiomáinfidh sé (is scéal fada é agus láimhseálann an próiseas tógála é seo).<br/><br/>Mar sin, úsáidimid riail rochtana eclipse chun é a eisiamh agus ní chuireann sé isteach orainn le linn forbartha.Ciallaíonn sé seo nach féidir linn an cód a athrú go héasca, ach tá sé ar cheann de na ranganna sin nach bhfuil i dteagmháil léi go litriúil i mblianta.<br/><br/>Is cás fíor-úsáide úsáid é Rialacha Rochtana Comhcheangail, a dhéanann breithiúnas ar an JavaDoc.Chun é a úsáid bheadh agat:<br/><br/>riail rochtana i bhfoinse onnmhairithe tionscadal amháin<br/><br/>nasc chuig an tionscadal sin ó thionscadal tuismitheora<br/><br/>an gá atá ann rialacha rochtana an fhothionscadail a chomhcheangal leis an tuismitheoir<br/><br/>Ní féidir liom a rá i ndáiríre conas a bheadh sé úsáideach, ach tá súil agam go dtugann ar a laghad do "cad é" ceist:) |
| Clues to heart disease in unexpected places, researchers discover<br/><br/>A major factor in the advance of heart disease is the death of heart tissue, a process that a team of scientists at Temple University School of Medicine's (TUSM) Center for Translational Medicine think could be prevented with new medicines. Now, the researchers are one step closer to achieving that goal, thanks to their discovery of a key molecule in an unexpected place in heart cells – mitochondria, tiny energy factories that house the controls capable of setting off cells' self-destruct sequence.<br/><br/>The study is the first to identify the molecule, an enzyme known as GRK2 (G protein-coupled receptor kinase 2), in mitochondria. It was led by Walter J. Koch, Ph.D., Professor and Chairman of the Department of Pharmacology at TUSM, and Director of the Center for Translational Medicine at TUSM.<br/><br/>"We have known that GRK2 is involved in the pathological development of certain heart diseases, such as chronic heart failure, and that its increased activity can lead to the death of heart cells. But its mechanism for the latter was unclear," Koch said. In addition, while the enzyme was known to be present in elevated levels in the hearts of patients with heart failure, the reasons for its rise were not fully understood.<br/><br/>Normally, GRK2 hangs out near the plasma membrane of heart cells, where it turns off certain signals transferred from the blood to the tissue. But the researchers at Temple found that it moves to mitochondria in response to two classic features of heart disease, ischemic insult and ensuing oxidative stress. These two processes, in which a momentary lapse in the delivery of oxygen-rich blood to diseased tissues causes a sudden increase in damaging reactive molecules, converge to stimulate the self-destruct program of heart cells. They ultimately cause whole sections of heart tissue to die, leaving behind scars that can severely compromise the ability of the heart to function properly.<br/><br/>Koch's team found that in ischemic heart cells the movement of GRK2 from the cell membrane to mitochondria is chaperoned by a substance called heat-shock protein 90 (Hsp90), which is produced in cells in response to stress. By blocking Hsp90's ability to bind to GRK2, the researchers were able to prevent the enzyme's delivery to mitochondria.<br/><br/>They reached the same result after mutating a residue called Ser670 in the tail end of GRK2's amino acid structure. When the Ser670 residue is activated by a chemical signal, Hsp90 is nudged into action, attaching to GRK2 and carrying it to mitochondria. Mutation of Ser670 also resulted in a wholesale reduction in pro-death signaling in affected heart cells. The effects were observed in human heart muscle cells grown in the laboratory and in mice that had experienced induced heart attacks. The results are detailed in the April 12 issue of the journal Circulation Research.<br/><br/>Koch explained that the translation of the new findings to the clinic, where they would benefit patients, lies in developing new therapeutic approaches that are capable of limiting both the activity of GRK2 and its ability to associate with mitochondria.<br/><br/>"We have a great opportunity here to develop new medicines against heart failure and improve upon this significant disease syndrome," he said. He added that this will take some time but that molecular and pharmacological strategies against GRK2 are in the works. "We are developing a gene therapy tool known as the ßARKct, which is a peptide inhibitor of GRK2, and are quite excited about a clinical trial."<br/><br/>Koch and his team have shown in pre-clinical studies that delivery of the ßARKct to failing hearts can inhibit GRK2 and thereby protect the heart from death. In the new study, ßARKct was found to block the enzyme's transit to mitochondria after ischemia, an important step now believed to contribute to the peptide's beneficial effects in heart failure.<br/><br/>There is much yet to learn about GRK2, however, according to Koch. "We still need to find out exactly what GRK2 is doing in the mitochondria," he said. "We need to figure out what it interacts with and specifically regulates."<br/><br/>What the team uncovers could solidify GRK2 as a key target for therapeutic strategies against heart disease.<br/><br/>Related Stories<br/><br/>Inhibition of a protein known to contribute to heart failure also appears to be protective of the heart in more acute cardiac stress injury, namely ischemia reperfusion, according to two studies conducted at the Center for Iowa researchers have previously shown that an enzyme called CaM kinase II plays a pivotal role in the death of heart cells following a heart attack or other conditions that damage or stress heart muscle. Loss | Pléann siad le galar croí in áiteanna gan choinne, faigheann taighdeoirí amach<br/><br/>Mórfhachtóir i bhfianaise an ghalair chroí is ea bás an fhíocháin croí, próiseas a d’fhéadfaí cosc a chur ar fhoireann eolaithe in Ionad na dTullscoil Leighis (TUSM) le haghaidh Leigheas Aistriúcháin le cógais nua. Anois, tá na taighdeoirí céim amháin níos gaire a bhaint amach an sprioc sin, a bhuíochas sin a fháil amach ar móilín lárnach in áit gan choinne i gcealla croí - mitochendria, monarchana fuinnimh beag bídeacha ina bhfuil na rialuithe in ann a leagan amach sraith féin-destruct cealla.<br/><br/>Is é an staidéar an chéad duine a aithint an móilín, einsím ar a dtugtar GRK2 (G próitéin-cúpláilte gabhdóir kinase 2), i mitochndria. Ba é Walter J. Koch, Ph.D., Ollamh agus Cathaoirleach na Roinne Cógaisíochta ag TUSM, agus Stiúrthóir an Ionaid um Leigheas Aistriúcháin ag TUSM a bhí i gceannas air.<br/><br/>Tá a fhios againn go bhfuil RK2 bainteach le forbairt paiteolaíoch galar croí áirithe, mar shampla teip chroí ainsealach, agus gur féidir le bás cealla croí a bheith mar thoradh ar a ghníomhaíocht mhéadaithe. Ach ní raibh a mheicníocht don dara ceann soiléir," a dúirt Koch. Ina theannta sin, cé go raibh sé ar eolas go raibh an einsím i láthair i leibhéil ardaithe i gcroí na n-othar le teip chroí, níor thuig sé go hiomlán na cúiseanna lena ardú.<br/><br/>De ghnáth, hangs RK2 amach in aice leis an membrane plasma na cealla croí, i gcás ina casadh sé as comharthaí áirithe a aistríodh as an fhuil chun an fíochán. Ach fuair na taighdeoirí ag an Temple go mbogann sé a mitochndiria mar fhreagra ar dhá ghné clasaiceach de ghalar croí, maslaí isecismeach agus ina dhiaidh sin strus ocsaídiúcháin. Déanann an dá phróiseas seo, ina mbíonn mall réidh le fuil ocsaigin-saibhir a sheachadadh ar fhíocháin galar méadú tobann ar móilíní díobhálacha, a chlúdach chun clár féinstruchtúrtha cealla croí a spreagadh. I ndeireadh na dála, cruthaíonn siad codanna iomlána den fhíochán croí le bás a fháil, ag fágáil taobh thiar de na coiléar a chuireann isteach go mór ar chumas an chroí feidhmiú i gceart.<br/><br/>Fuair foireann Koch, a tháirgtear i gcealla croí is é an ghluaiseacht RK2 ó membrane cille go mitochondrria le substaint ar a dtugtar próitéin teas-shock 90 (Hsp90), a tháirgtear i gcealla mar fhreagra ar strus. Trí bhac a chur ar chumas Hsp90 ceangal a chur le GRK2, bhí na taighdeoirí in ann seachadadh an einsím a chosc chuig mitochndria.<br/><br/>D'éirigh leo an toradh céanna a bhaint amach tar éis iarmhar ar a dtugtar struchtúr aimínaigéid Ser670 a uasmhéadú.Nuair a chuirtear an t-iarmhar Ser670 i ngníomh le comhartha ceimiceach, tá Hsp90 claonta i ngníomh, ag gabháil le GRK2 agus é a sheoladh chuig mitochndria. Mar thoradh ar sóchán ser670 bhí laghdú iomlán ar an solas i comhartha réamh-bháis i gcealla croí atá ag dul i bhfeidhm ar na héifeachtaí a breathnaíodh i gcealla croí an duine a fhástar sa tsaotharlann agus i lucha a bhí tar éis ionsaithe croí a spreagadh. Tugtar mionsonraí ar na torthaí in eagrán 12 Aibreán den taighde ar chúrsaí iriseoireachta.<br/><br/>Mhínigh Koch go bhfuil aistriúchán na dtorthaí nua don chlinic, áit a rachadh siad chun sochair d'othair, cur chuige teiripeach nua a fhorbairt atá in ann gníomhaíocht RK2 agus a cumas a chomhbhaint le miocndria.<br/><br/>Tá deis iontach againn anseo cógais nua a fhorbairt i gcoinne teip croí agus feabhas a chur ar an siondróm galar suntasach seo," a dúirt sé. Dúirt sé go dtógfaidh sé seo roinnt ama ach go bhfuil straitéisí móilíneacha agus cógaisíochta i gcoinne GRK2 sna hoibreacha. Táimid ag forbairt uirlis teiripe géine ar a dtugtar an ßARKct, a bhfuil inhibitor peiptíde de GRK2, agus atá ar bís go leor faoi thriail chliniciúil."<br/><br/>Tá sé léirithe ag Koch agus a fhoireann i staidéir réamhchliniciúla gur féidir le seachadadh an ßARKct chun croíthe teipe RK2 a chosc agus ar an gcaoi sin an croí a chosaint ón mbás. Sa staidéar nua, fuarthas amach go raibh ßARKct bac ar idirthuras an einsím go dtí mitochondia tar éis éicéim, céim thábhachtach a chreid anois chun cur le héifeachtaí tairbhiúla an peptide i teip chroí.<br/><br/>Tá a lán fós le foghlaim faoi RK2, áfach, de réir Koch. "Ní mór dúinn fós a fháil amach go díreach cad atá á dhéanamh ag RK2 sa mitochndria," a dúirt sé. "Ní mór dúinn a dhéanamh amach cad a bhíonn sé ag idirghníomhú le agus rialaíonn sé go sonrach."<br/><br/>Cad a d'fhéadfadh an fhoireann uncover RRK2 mar phríomhsprioc do straitéisí teiripeacha i gcoinne galar croí.<br/><br/>Scéalta ghaolmhara<br/><br/>Is cosúil go bhfuil toirmeasc ar fhine próitéine ar a dtugtar cur le teip chroí cosanta freisin ar an gcroí i ndíobhálacha strus níos géarmhíochaine, eadhon reperfusion iseemia, de réir dhá staidéar a rinneadh ag an Ionad do thaighdeoirí Iowa roimhe sin go bhfuil ról lárnach ag einsím cam ar a dtugtar I kinase i bhfás na gcealla croí tar éis ionsaí croí nó coinníollacha eile a dhéanann díobháil nó strus muscle croí. Caillteanas |
| Slide 1: ==== ==== How To Cure Angular Cheilitis -- Success Guaranteed -- CLICK BELOW  ==== ====<br/>Angular cheilitis is an inflammatory lesion at the corner of the mouth and often occurs bilaterally. It is often characterized by cracks or deep fissures. In severe cases, the cracks may bleed when the mouth is opened and shallow ulcers or a crust may form. Although the sores of angular cheilitis may later become infected by the fungus Candida albicans or other pathogens, studies have linked the onset of angular cheilitis with nutritional deficiencies, particularly riboflavin (vitamin B 2) and iron deficiency, which in turn may be indicative of a poor diet or malnutrition. Zinc deficiency has also been associated with angular cheilitis. Other causes can be: the papilloma virus, stress, antibiotics, allergic substances and sunburn. How to treat angular cheilitis naturally at home:<br/>Keep your lips moisturized at all times: you can do that by applying unflavored lip balm or gloss or an aloe Vera gel. You can also use several natural home remedies, such as: Vitamin E: buy Vitamin E capsules and break them with a sterilized needle. Then apply the Vitamin E oil to the affected areas to treat cheilitis. Cucumber: just cut a piece of cucumber and rub it on your mouth. Neem leaf: rub neem leaf distill on the afflicted areas. Olive oil: Rub some olive oil over your lips. Honey: apply honey on your lips and wash it off after at least 15 minutes. Honey has excellent antibacterial properties and can help the healing process. Eat better and healthier: the best way to prevent and treat cheilitis is to nourish your body from the inside. Try to eat foods that are rich in vitamin B (brewer's yeast, legumes, fish, potatoes, peanuts, eggs, poultry, liver, meat, milk, brown rice, soybeans, butter and whole grain cereals) and iron (liver, oysters, pumpkin seeds, spinach, prunes, artichokes, canned beans, sardines and shrimps). An easy way to get all the vitamins you need for an effective angular cheilitis treatment is to take Vitamin B12 and Vitamin B1 supplements to boost your immune system and help your body fight off the bacteria and eliminate the disease. Avoid drinking orange juice: Orange juice is very acidic and can irritate the delicate skin at the corners of your mouth and also cause a lot of pain. If you really want to drink some orange juice, you can just use a straw. There are also other foods that can create irritation, such as spicy foods, lemonade and citrus fruits in general, so stay away from these foods, if you don't want to make this condition worse.<br/>Next find out the #1 method to Treat Angular Cheilitis Naturally! Just Click here to find out how!<br/>Slide 2: Article Source: <br/>==== ==== How To Cure Angular Cheilitis -- Success Guaranteed -- CLICK BELOW  ==== ==== | Sleamhnú 1: ===== Conas Ceilitiseas Dronuilleach A Leigheas -- Rath Rath Ráthaithe --CLIW =============<br/>I gcásanna tromchúiseacha, d’fhéadfadh go mbeadh na scoilteanna bleeding nuair a osclaítear an béal agus a swallow ulcers nó screamh d’fhéadfadh foirm.Is minic a bhíonn sé tréithrithe ag scoilteanna nó go domhain. Cé gur féidir leis an lesbians fungas Candida nó pataiginí eile dul faoi chois, tá staidéir nasctha leis an tús chileaitis uilleach le heasnaimh cothaitheacha, go háirithe ribín B2) agus easnamh iarainn, a d'fhéadfadh a bheith táscach ina dhiaidh sin ar dhroch-aiste bia nó míchothú. Tá baint ag easnamh since le héileaitis uilleach freisin.Is féidir le cúiseanna eile a bheith: an víreas papilloma, strus, antaibheathaigh, substaintí ailléirgeacha agus grianchloch.<br/>Coinnigh do liopaí moisturized i gcónaí: is féidir leat é sin a dhéanamh trí chur i bhfeidhm maolán liopaí neamhbhlastha nó snasta Vera nó glóthach alód.Is féidir leat roinnt leigheasanna baile nádúrtha a úsáid freisin, mar shampla: Vitimín E: capsúil agus iad a bhriseadh le snáthaid steiriliú. Ansin cuir ola Vitimín E i bhfeidhm ar na réimsí ina bhfuil tionchar orthu chun chiliitis a chóireáil. Cuber: just píosa cúcamar a ghearradh agus é a chuimil ar do bhéal. Mil: iarratas a dhéanamh mil ar do liopaí agus nigh sé amach tar éis ar a laghad 15 nóiméad.Tá airíonna antibacterial den scoth ag Mil agus is féidir cabhrú leis an bpróiseas leighis. Ith níos fearr agus níos sláintiúla: is é an bealach is fearr le héileaitis a chosc agus a chóireáil ná do chorp a chothú ón taobh istigh. Bain triail as a ithe bianna atá saibhir i vitimín B (gathanna, iasc, prátaí, peanuts, uibheacha, éanlaithe clóis, ae, feoil, bainne, rís donn, soybens, im agus gránaigh iomlán) agus iarann (aeliver, oisrí, síolta pumpkin, spionáiste, pinn luaidhe, tartokes, pónairí stánaithe, sardines agus shrimps). Bealach éasca chun na vitimíní go léir a theastaíonn uait a fháil le haghaidh cóireáil éifeachtach héiliitis uilleach Vitimín B12 agus forlíontaí Vitimín B1 a ghlacadh chun do chóras imdhíonachta a threisiú agus chun cabhrú le do chorp troid as na baictéir agus deireadh a chur leis an ngalar. Seachain sú oráiste: Tá sú oráiste an-aigéad agus is féidir leis an gcraiceann íogair a ghreanadh ag coirnéil do bhéal agus a lán pian a chur faoi deara.Más mian leat sú oráiste a ól,is féidir leat tuí a úsáid. Tá bianna eile ann freisin ar féidir leo greannú a chruthú, mar shampla bianna spicy, líomanáid agus torthaí citris go ginearálta, mar sin fanacht ar shiúl ó na bianna seo, más rud é nach bhfuil tú ag iarraidh an coinníoll seo a dhéanamh níos measa.<br/>Ar aghaidh, faigh amach an modh #1 chun Ceilitis Dronuilleach a Chaitheamh ar ndóigh! Cliceáil anseo le fáil amach conas!<br/>Sleamhnán 2: Foinse Airteagal:<br/>= ===== Conas Ceilitis a Ríomhshuíomh - Rath Rath Ráthaithe --CLIW =========== |
| Kind Hearts And Cauliflowers<br/><br/>It sort of chokes you up when you think of the beautiful friendship between Jake Mintz and his boy, Wilf Greaves<br/><br/>Yet when Greaves retired last year and went to work on the Detroit docks, boxing men familiar with Jake Mintz's genius had not the slightest doubt that, had Jake lived on, he somehow would have finagled a shot at the world title for Wilf. Somehow he would have sneaked him beyond the edge. And who knows? Wilf might have met a champion on an off night and won the title. | Hearts Cineál Agus Caulflowers<br/><br/>Cuireann sé saghas chokes tú suas nuair a cheapann tú de na cairdeas álainn idir Jake Miniz agus a buachaill, Wolf Greaves<br/><br/>Ach nuair a d'éirigh Greaves ar scor anuraidh agus chuaigh sé ag obair ar na duganna Detroit, ní raibh an amhras is lú ar fhir dornálaíochta le genius Jake Mintz, go raibh Jake ina gcónaí orthu, go mbeadh lámhaigh tugtha air ar bhealach éigin ag teideal an domhain do Wilf. Ar bhealach éigin bheadh sé sneaked sé é níos faide ná an imeall. Agus a bhfuil aithne aige? D'fhéadfadh a bheith tagtha le chéile laoch ar oíche amach agus bhuaigh an teideal. |
| Featured ResearchShare ThisIntensive care patients are especially vulnerable to picking up infections in hospital, due to their poor health. Researchers from the Karolinska Institutet in Sweden found that 70% of intensive care patients studied were colonized with bacteria from other patients in the unit.<br/><br/>The researchers investigated the transmission of several strains of Staphylococcus bacteria, called CoNS. These strains are the primary cause of circulatory infections picked up in hospitals, and the third most common cause of all hospital infections. "These species have the ability to survive in the ICU surroundings on medical devices and equipment for weeks up to months," say the researchers. "They are specifically prone to causing catheter-related infections."<br/><br/>The team, led by Professor Charlotta Edlund, took swabs from the upper and lower airways of 20 intensive care patients that had required mechanical ventilation for at least three days. The researchers cultured the bacteria from these swabs and analysed the genetic fingerprints of Staphylococcus strains to identify bacteria that were identical or closely related. They could then assess the transmission rates of bacteria between patients, by seeing which patients harboured the same bacterial strains.<br/><br/>17 of the patients were colonised by CoNS during their hospital stay. In six of these cases, the bacteria had colonised the lower airways after the patient was ventilated, suggesting that the procedure itself had introduced the bacteria. 14 of the patients had either passed on a bacterial strain to another patient or received a bacterial strain from another patient. Worryingly, one patient passed on bacteria to a patient they had never met, having being discharged about three weeks prior to the other's arrival. This implies that the strain had survived in the ward during this period, perhaps on staff or on additional patients.<br/><br/>"Local guidelines for antibiotic use, close cooperation with infectious diseases specialists and restrictions with invasive treatment are strategies that can improve infection control and lower the incidence of hospital infections," write the authors. "Hand hygiene among hospital staff is [also] an important factor for preventing these infections."<br/><br/>The antibiotic resistance of the bacterial strains was analysed. 95% were resistant to penicillin, 86% to oxacillin, 48% to erythromycin, 42% to clindamycin, 54% to gentamicin, and 66% to ciprofloxacin. None were resistant to vancomycin, which is currently used to treat MRSA and other infections caused by other antibiotic-resistant bacteria.<br/><br/>Resistance to multiple antibiotics was commonly seen. 21% of the bacterial strains were resistant to six, 34% to at least five, and 59% to at least four of the tested antibiotics. "This multi-resistance will lead to higher consumption of broadspectrum antibiotics such as vancomycin, promoting the development of antibiotic resistance."<br/><br/>CoNS normally live on our skin without causing us any harm, but they can colonise airways or invasive devises (such as tubes used in mechanical ventilation), especially in people with weak immune systems. Although these bacteria do not always cause disease, colonisation is a risk factor for infection with other, more dangerous, antibiotic resistant bacterial strains. 13, 2011 — Expanded use of active surveillance for bacteria and of barrier precautions -- specifically, gloves and gowns -- did not reduce the transmission of two important antibiotic-resistant bacteria in ... full story<br/><br/>Feb. 24, 2011 — Infections are among the most frequent complications of a stay in hospital and raise the complication and mortality rates. New calculations have shown an incidence of almost 60,000 newly acquired | Taighde GnéitheTá na hothair dhiana seo leochaileach go háirithe chun ionfhabhtuithe a phiocadh san ospidéal, mar gheall ar a drochshláinte. Fuair taighdeoirí ó Institiúid Karolinska sa tSualainn amach go raibh 70% d'othair dianchúraim i gceist le baictéir ó othair eile san aonad.<br/><br/>Rinne na taighdeoirí imscrúdú ar tharchur roinnt tréithchineálacha baictéir Staphylococcus, ar a dtugtar CONS. Is iad na tréithigh seo an chúis is mó le ionfhabhtuithe imshruthaithe atá piocadh suas in ospidéil, agus an tríú cúis is coitianta de gach ionfhabhtú ospidéil. Tá sé de chumas ag na speicis seo maireachtáil i dtimpeallacht an ICU ar fheistí agus trealamh leighis suas le míonna," a rá leis na taighdeoirí. "Tá seans maith acu go sonrach ionfhabhtuithe a bhaineann le catera a dhéanamh."<br/><br/>Ghlac an fhoireann, faoi stiúir an Ollaimh Charlotte Edmund, swabanna ó na haerbhealaí uachtair agus íochtaracha 20 othar dianchúraim a raibh aeráil mheicniúil de dhíth orthu ar feadh trí lá ar a laghad. Rinne na taighdeoirí na baictéir a shaothrú ó na swabanna seo agus rinne siad anailís ar mhéara géiniteach tréithchineálacha Staphylococcus chun baictéir a bhí comhionann nó dlúth-ghaolmhar a aithint. D’fhéadfaidís na rátaí tarchurtha baictéir a mheas ansin idir othair, trína fheiceáil cé na hothair a raibh na tréithchineálacha baictéaracha céanna acu.<br/><br/>I sé cinn de na cásanna seo, choilíníodh na baictéir na haerbhealaí níos ísle tar éis don othar a aerú, rud a thug le fios go raibh na baictéir tugtha isteach sa nós imeachta féin. Bhí 14 de na hothair tar éis dul ar aghaidh ar brú baictéarach chuig othar eile nó bhí brú baictéarach orthu ó othar eile. Go huafásach, chuaigh othar amháin ar aghaidh chuig baictéir chuig othar nár bhuail siad riamh, tar éis dóibh a bheith scaoilte thart ar thrí seachtaine roimh theacht an duine eile. Tugann sé seo le tuiscint gur mhair an brú sa bharda le linn na tréimhse seo, b’fhéidir ar an bhfoireann nó ar othair bhreise.<br/><br/>Is straitéisí iad "treoirlínte áitiúla maidir le húsáid antaibheathach, dlúthchomhoibriú le speisialtóirí galar tógálach agus srianta a bhfuil cóireáil ionrach orthu, ar féidir leo rialú ionfhabhtaithe a fheabhsú agus minicíocht ionfhabhtuithe ospidéil a ísliú," a scríobh na húdair. Is fachtóir tábhachtach é "sláinte láimhe i measc baill foirne ospidéil [chomh maith leis sin chun na hionfhabhtuithe seo a chosc".<br/><br/>Rinneadh anailís ar fhriotaíocht antaibheathach na srianta baictéarach. Bhí 95% frithsheasmhach in aghaidh peinicillin, 86% go hocsaídeach, 48% do rythromycin, 42% do clindamycin, 54% go gentamicin, agus 66% do ciprofloxacin. Ní raibh aon cheann acu resistant a vancomycin, a úsáidtear faoi láthair chun MRSA agus ionfhabhtuithe eile a chóireáil de bharr baictéir antaibheathach eile.<br/><br/>Measadh go coitianta go raibh friotaíocht ar antaibheathaigh iolracha. Bhí 21% de na tréithí baictéarach frithsheasmhach in aghaidh sé, 34% ar a laghad cúig, agus 59% go dtí ceithre cinn ar a laghad de na hantaibheathaigh tástála. "Beidh an il-fhriotaíocht mar thoradh ar úsáid níos airde na n-antaibheathaigh leathanbhanda cosúil le Vancomycin, forbairt friotaíochta antaibheathach a chur chun cinn."<br/><br/>De ghnáth bíonn CONS ina gcónaí ar ár gcraiceann gan aon dochar a dhéanamh dúinn, ach is féidir leo aerbhealaí nó gairis ionracha a choilíniú (cosúil le feadáin a úsáidtear i aeráil mheicniúil), go háirithe i ndaoine a bhfuil córais imdhíonachta lag acu. Cé nach mbíonn na baictéir seo faoi deara i gcónaí galar, is fachtóir riosca é comhdhlúthú le haghaidh ionfhabhtú le tréithchineálacha baictéarach eile, níos contúirtí, resistant antaibheathach. 13, 2011 - Níor laghdaíodh an úsáid fhada a bhaineas as faireachas gníomhach ar bhaictéir agus ar bhaic - go sonrach, lámhainní agus gowns - - - níor laghdaíodh tarchur dhá baictéir a bhaineann le antaibheathach tábhachtach i...<br/><br/>Feabhra 24, 2011 — I measc na n-ionfhabhtuithe is minice a bhíonn ag fanacht san ospidéal agus na rátaí deacrachta agus básaithe a ardú. |
| Some Amish and Mennonites suffer rare genetic problems<br/><br/>Some Amish and Mennonite individuals struggle with genetic conditions little-seen in the general population. Certain Amish populations also exhibit diseases and conditions seen elsewhere, but at a higher rate than the general public. Amish and related groups have been assisted by outsiders in treating genetic problems.<br/><br/>What genetic diseases are common among Amish and Mennonites?<br/><br/>Amish and Mennonites exhibit certain rare diseases uncommon in other populations. These include Ellis-van Creveld syndrome (a type of dwarfism), glutaric aciduria, Crigler-Najjar syndrome, and maple syrup urine disease. Some illnesses are so uncommon that they are unique to these communities (such as Troyer Syndrome or Amish lethal microcephaly), or rarely seen elsewhere.<br/><br/>Some groups of Amish may exhibit diseases more likely to be seen in the general public, but at a higher rate. These include cystic fibrosis, muscular dystrophy and deafness in some communities.<br/><br/>Amish suffer genetic problems for a few reasons:<br/><br/>Small founding groups-individual Amish communities typically originate from relatively few families. Almost all of the Amish in Lancaster County, for example, originated from a few dozen 18th-century immigrant families.<br/><br/>Genetic isolation-converts to the Amish have been rare, and Amish only marry other Amish. This practice of endogamy, with few new bloodlines entering the population, has led to limited variation of genes.<br/><br/>Lancaster Amish descend from a small group of 18th-century immigrants<br/><br/>These two factors combine to create a "founder effect". A founder effect means that genetic variation is lost over time due to a limited number of founding individuals. Certain recessive traits found in a small founding population are amplified in future generations.<br/><br/>Additionally, most Amish tend to focus religious energies on their own sizeable families, as opposed to proselytizing others. These two factors make it unlikely for outsiders to join the Amish, a process by which the Amish genetic pool would otherwise be deepened over time.<br/><br/>Help for Amish and Mennonites with hereditary illnesses<br/><br/>Amish and outsiders sympathetic to their challenges have focused on early diagnosis and treatment of genetic illnesses in their communities. A number of institutions assist Amish and Mennonite families afflicted by inherited genetic disorders.<br/><br/>The Clinic for Special Children Benefit Auction is held annually in a number of places, including Leola in Lancaster County<br/><br/>The best-known is The Clinic for Special Children, located in Strasburg in Lancaster County. The Clinic, run by Dr. Holmes Morton, operates thanks to contributions, proceeds from annual benefit auctions taking place in Pennsylvania and Ohio, and by charging relatively small fees for services. The Clinic for Special Children also treats children from outside the Amish and Mennonite community and from around the world.<br/><br/>Other medical institutions, such as the Akron, Ohio Children's Hospital and the SUNY Upstate Medical University accommodate Amish and Mennonite patients, as in the case of cystic fibrosis treatment, for example.<br/><br/>Researchers fairly frequently enlist Amish help in conducting genetic studies, such as recent research on the presence of a "fat gene" in Amish individuals. Amish, increasingly aware of the benefits genetic research can bring to others and themselves, generally participate in large numbers.<br/><br/>Intermarriage across Amish society may be another solution to genetic issues, as Amish in different communities exhibit different bloodlines. However, differences in practice between Amish affiliations may prevent such intermarriage from occurring. Marriage between communities such as Lancaster County and Holmes County, Ohio, occur only rarely.<br/><br/>Enjoy this post? Subscribe by email to get updates from Amish America:<br/><br/>Related Articles to Do Amish have genetic disorders?<br/><br/>Genetic Treatment in the Plain Population You may be aware of the Clinic for Special Children in Strasburg, Pennsylvania, which treats children suffering from rare genetic illnesses, primarily within the Amish and Mennonite populations. The clinic…<br/><br/>Do we romanticize the Amish? When I first began spending time with the Amish, I felt like I was entering another world. I would drive my car from gritty Decatur, Illinois, where I was living…<br/><br/>Do Amish practice inbreeding? Today's question springs from a new study on a genetic mutation which causes a form of mental retardation among Amish. Like other genetic research involving the Amish, this study will probably…<br/><br/>Amish Tech Conference registration now open As mentioned before, this spring the Young Center for Anabaptist and Pietist Studies at Elizabethtown College will be hosting a 3-day conference entitled "Amish America: Plain Technology in a Cyber…<br/><br/>4 responses to Do Amish have genetic disorders?<br/><br/>I am doing a research paper on Amish genetic disorders and was wondering if there was more to the article listed above, or if you have nay more inforamtion regarding this topic. If you could contact me, I would appreciate it greatly. I can also be reached by phone at 302-690-4427. Thank you for your time.<br/><br/>In over 25 years living in an Amish community, I've witnessed a distressing and frightening array of genetic disorders among the children. Recently, however, I attended a presentation by a snake oil salesman who could have come straight out of a Gunsmoke episode. He insisted none of the maladies afflicting the children or others are genetic. He claimed they're all caused by dietary deficiencies. It was a throwback to the dark ages. If they bought his "nutrition supplements" then it would cure epilepsy, muscular dystrophy, downes syndrome and impotency, among others. He is misleading people and will injure them. Whats to be done with this fraud?<br/><br/>Has there been any effort toward education regarding the claims of the "snake oil" salesman? So many times people (or their families)who have been affected by a disorder that they cannot personally control are vulnerable to anything that comes along that feel gives some measure of managing the problem.<br/>Considering the practices of raising families inside a very small gene pool, it is a certainty that the incidence of these disorders will increase.<br/>Very sad.<br/><br/>Is there proof that these supplements wouldn't work? Perhaps not for some of these conditions, but other supplements have been well known to help aid a body to cure itself of a disease, such as cancer, Fibromyalgia (I hear a rising occurrence among the Amish), MS, Diabetes, etc. Remember that these supplements (if a good quality) may very well be those vitamins and minerals that we are lacking in modern diets, and the Amish diet in many places can be lacking, though I know many are as concerned about mainstream diets and their deficiencies. We have a doctor in Colorado who is primarily homeopathic but has his medical degree. He has a very high success rate using supplements and raw foods/juices to rid the body of cancer and other ailments, such as Fibromyalgia. And supplements and essential oils are all natural medicines given to us by God and largely overlooked by the population at large. Something that may appear to be "snake oil" to some, may very well be exactly what is needed. I don't know the individual persons, so I can't really comment on that. Recently, a purdue study showed that the fruit of the Soursop (graviola) tree killed cancer cells 10,000 times better than chemo drugs. Why is it not known? It could never be synthesized. They tried for seven years. | Tá fadhbanna géiniteacha annamh ag cuid d’Amish agus Mennites<br/><br/>Bíonn daoine aonair ag streachailt le riochtaí géiniteacha beagán le feiceáil sa phobal i gcoitinne.Taispeánann daonraí áirithe Amish galair agus coinníollacha in áiteanna eile freisin, ach ag ráta níos airde ná an pobal i gcoitinne. Thug daoine ón taobh amuigh cúnamh do ghrúpaí a bhfuil baint acu le cóireáil a dhéanamh ar fhadhbanna géiniteacha.<br/><br/>Cad iad na galair ghéiniteach atá coitianta i measc Amish agus Menninotes?<br/><br/>Taispeánann Amish agus Mennites galair neamhchoitianta áirithe i ndaonraí eile.Cuimsíonn siad seo siondróm Creveld Ellis-van (cineál diffrism), glúciraria, siondróm Crigler-Najjar, agus galar fuail síoróip maple. Tá roinnt tinneas neamhchoitianta go bhfuil siad uathúil do na pobail seo (mar shampla Traoi Siondróm nó Amish mharfach), nó annamh a fheiceáil in áiteanna eile.<br/><br/>D’fhéadfadh roinnt grúpaí d’Amis galar a bheith níos dóchúla a bheith le feiceáil sa phobal i gcoitinne, ach ag ráta níos airde. Ina measc seo tá snáithíní cistéitíc, mhatánach agus bodhra i roinnt pobail.<br/><br/>Tá fadhbanna géiniteacha ag Íosa ar roinnt cúiseanna:<br/><br/>Is iondúil gur as mórán teaghlach a thagann grúpaí beaga bunaithe in Amish, beagnach gach ceann de na hArmaí i gContae Lancaster, mar shampla, a tháinig ó chúpla dosaen teaghlach inimirceach ón 18ú haois.<br/><br/>Is annamh a bhí aonrú ginealach i gcoinne an Amaigh, agus ní phósann Íosa ach Arm eile. Is beag fuilteach nua a théann isteach sa daonra, a bheag nó a mhór a bhí athrú teoranta ó ghéins.<br/><br/>Lancaster Amus descend ó ghrúpa beag inimircigh ón 18ú haois<br/><br/>Ciallaíonn éifeacht bunaitheoir an dá fhachtóir seo go gcailltear athrú géiniteach le himeacht ama mar gheall ar líon teoranta daoine bunaithe. Déantar tréithe áirithe a fhaightear i ndaonra beag bunaithe aimpliú sna glúine amach anseo.<br/><br/>Ina theannta sin, is gnách go ndíríonn an chuid is mó d’Amish ar fhuinneamh reiligiúnach ar a dteaghlaigh inmhéide féin, seachas daoine eile a ionchúiseamh. Mar gheall ar an dá fhachtóir seo ní dócha go mbeidh daoine ón taobh amuigh ag dul isteach san Eaglais, próiseas trína neartófaí an linn géiniteach Amish ar shlí eile le himeacht ama.<br/><br/>Cabhair le haghaidh Amish agus Mennites le tinneas oidhreachtúil<br/><br/>Dhírigh Amish agus daoine ón taobh amuigh ar luathdhiagnóisiú agus ar chóireáil tinneas géiniteach ina bpobail. Tá roinnt institiúidí ag cuidiú le teaghlaigh as Éirinn agus le Mainistir na Corann atá buailte ag neamhoird géiniteacha le hoidhreacht.<br/><br/>Reáchtáiltear an Clinic chun Sochar Leanaí Speisialta gach bliain i roinnt áiteanna, lena n-áirítear Leola i gContae Lancaster<br/><br/>Is é an Clinic do Leanaí Speisialta, atá lonnaithe in Strasbourg i gContae Lancaster, an ceann is fearr aithne air. Oibríonn an Clinic, atá á reáchtáil ag an Dr. Holmes Morton, a bhuíochas le ranníocaíochtaí, fáltais ó cheantanna sochair bhliantúla a bhíonn ar siúl i Pennsylvania agus Ohio, agus trí tháillí réasúnta beag a ghearradh as seirbhísí. Déileálann an Clinic do Leanaí Speisialta le leanaí ó lasmuigh den phobal Amish agus Mhainistir na Corann agus ó gach cearn den domhan.<br/><br/>Déanann institiúidí leighis eile, mar shampla an Akron, Ospidéal na Leanaí Ohio agus Ollscoil Leighis Nua-Aimseartha freastal ar othair Aimsithe agus Mhainistir na Corann, mar shampla.<br/><br/>Is minic a liostálann taighdeoirí Amish cabhair chun staidéir ghéiniteach a dhéanamh, mar shampla taighde le déanaí ar láithreacht “gine saille” i ndaoine aonair Amish. Is féidir le hArdach, níos mó ar an eolas faoi na buntáistí a bhaineann le taighde géiniteach daoine eile agus iad féin a thabhairt chun páirt a ghlacadh i líon mór de ghnáth.<br/><br/>D’fhéadfadh réiteach eile a bheith ar shaincheisteanna géiniteacha idir an t-idirghabhálaí ar fud shochaí Luimnigh, mar a thaispeánann Amish i bpobail éagsúla fuileanna éagsúla. Mar sin féin, d’fhéadfadh difríochtaí sa chleachtas idir cleamhnachtaí Íosa tarlú. Is annamh a tharlaíonn pósadh idir pobail ar nós Chontae Lancaster agus Contae Holmes, Ohio, ach amháin.<br/><br/>Bain sult as an bpost seo? Liostáil trí r-phost chun nuashonruithe a fháil ó Amish America:<br/><br/>Earraí gaolmhara le hÍosa a bhfuil neamhoird géiniteacha acu?<br/><br/>B’fhéidir go bhfuil tú ar an eolas faoin gClinic do Leanaí Speisialta in Strasbourg maidir le Pennsylvania, a dhéileálann le leanaí a bhfuil tinneas géiniteach annamh orthu, go príomha laistigh de dhaonra na n-Amish agus na Seanaidh.<br/><br/>Nuair a thosaigh mé ag caitheamh ama leis an Amis, is dóigh liom go raibh mé ag dul isteach i ndomhan eile.Ba mhaith liom mo charr a thiomáint ó Goctur grity, Illinois, áit a raibh mé i mo chónaí...<br/><br/>An bhfuil cleachtas Amis ag inbrebeding?Scéala cheist an lae inniu ó staidéar nua ar shóchán géiniteach a chruthaíonn cineál athmhúnlú meabhrach i measc Amish. Cosúil le taighde géiniteach eile a bhaineann leis an Amish, is dócha go mbeidh an staidéar seo...<br/><br/>Osclófar clárú Comhdháil Teicneolaíochta Ard-Amish anois mar a luadh cheana, an t-earrach seo beidh Ionad na nAbptist agus Léann Pietist i gColáiste Eiltown ag óstáil comhdháil 3 lá dar teideal "Amish America: Plain Technology in a Cyber...<br/><br/>4 fhreagraí ar An bhfuil neamhoird ghéiniteach ag Amish?<br/><br/>Tá páipéar taighde á dhéanamh agam ar neamhoird géiniteach Amish agus bhí sé ag smaoineamh an raibh níos mó den alt liostaithe thuas, nó an bhfuil aon fhaisnéis eile agat maidir leis an ábhar seo.Má d’fhéadfá teagmháil a dhéanamh liom, bheinn buíoch go mór é. Is féidir liom teagmháil a dhéanamh freisin ar an bhfón ag 30-690-4427.<br/><br/>Le breis agus 25 bliain ina gcónaí i bpobal Aimsithe, chonaic mé réimse neamhoird géiniteacha i measc na leanaí. Le déanaí, áfach, d'fhreastail mé ar chur i láthair ag salesman ola nathair a d'fhéadfadh teacht díreach amach as eipeasóid Gunsmoke., D'áitigh sé nach bhfuil aon cheann de na maladies cur isteach ar na páistí nó daoine eile géiniteach. D'éiligh sé go bhfuil siad go léir de bharr easnaimh aiste bia.Bhí sé ina suaitheadh mór ar na haoiseanna dorcha.Má cheannaigh siad a chuid "forlíontaí cothaithe" ansin leigheasfadh sé titimeas, mhatánach diosturdy, downs siondróm agus impotence, i measc daoine eile. Tá sé daoine míthreoracha agus ghortóidh sé iad. Cad atá le déanamh leis an gcalaois seo?<br/><br/>An raibh aon iarracht i dtreo an oideachais maidir leis na héilimh ar an "ola nathair" salesman? Mar sin, go leor uaireanta bíonn daoine (nó a dteaghlaigh) a ndeachaigh neamhord i bhfeidhm orthu nach féidir leo rialú a dhéanamh go pearsanta ar rud ar bith a thagann chomh maith leis sin tugann beart éigin chun an fhadhb a bhainistiú.<br/>Ag smaoineamh ar chleachtais a bhaineann le teaghlaigh a thógáil taobh istigh de linn snámha géa beag, is cinnte go méadóidh minicíocht na neamhoird seo.<br/>An-brónach.<br/><br/>An bhfuil cruthúnas ann nach n-oibreodh na forlíontaí seo? B’fhéidir nach bhfuil cuid de na coinníollacha seo, ach bhí forlíonta eile ar eolas go maith chun cabhrú le comhlacht leigheas a dhéanamh air féin ar ghalar, mar shampla ailse, Fibromyalgia (cuala mé ag ardú i measc an Amis), MS, Diabetes, etc. Cuimhnigh go bhféadfadh na forlíonta seo (má tá dea-chaighdeán) a bheith go han-mhaith leis na vitimíní agus leis na mianraí sin atá in easnamh againn i réim bia nua-aimseartha, agus is féidir leis an aiste bia fhórsaí a bheith in easnamh i go leor áiteanna, cé go bhfuil a fhios agam go leor go bhfuil imní orm faoi aistí bia príomhshrutha agus a n-easnamh. Tá dochtúir againn in Colorado atá homeopathic go príomha ach a bhfuil a chéim leighis aige.Tá ráta ratha an-ard aige ag baint úsáide as forlíontaí agus bianna / súnna amh chun comhlacht ailse agus tinnis eile a thiomána, mar Fibromyalgia. Agus is iad forlíonta agus blátholaí na cógais nádúrtha go léir a thugann Dia dúinn agus a dhéanann an daonra a imscrúdú go mór den chuid is mó.D’fhéadfadh go mbeadh rud éigin a d’fhéadfadh a bheith cosúil le "ola nathair" a roinnt, go han-mhaith go díreach cad atá ag teastáil. Tá a fhios agam na daoine aonair, mar sin ní féidir liom trácht a dhéanamh air.Le déanaí, léirigh staidéar dian gur maraíodh torthaí an chrainn Sosurop (viola) cealla ailse 10,000 uair níos fearr ná drugaí chemo. Ní fhéadfaí é a shintéisiú riamh. Rinne siad iarracht ar feadh seacht mbliana. |
| Which political party in the United States has claimed to represent the interests of the working class and the disadvantaged since the early 1900s?<br/>A. the Democratic Party<br/>B. the Libertarian Party<br/>C. the Progressive Party<br/>D. the Republican Party<br/><br/>A. the Democratic Party is political party in the United States that has claimed to represent the interests of the working class and the disadvantaged since the early 1900s | Cén páirtí polaitiúil sna Stáit Aontaithe a d'éiligh ionadaíocht a dhéanamh ar leasanna an ranga oibre agus na ndaoine atá faoi mhíbhuntáiste ó thús na 1900idí?<br/>A. an Páirtí Daonlathach<br/>B. an Páirtí Liobrálach<br/>C. an Páirtí Forchéimnitheach<br/>D. an Páirtí Poblachtach<br/><br/>A. Is é an Páirtí Daonlathach páirtí polaitiúil sna Stáit Aontaithe a d'éiligh chun ionadaíocht a dhéanamh ar leasanna an ranga oibre agus na ndaoine faoi mhíbhuntáiste ó luath sna 1900idí |
| It's not functioning like a normal shuffle does. it processes through the songs, but does not catch a song after the shuffle starts. Also, if I press a song to play without shuffle, it flashes the song, then goes back to the playlist.<br/><br/>The same songs on my macbook and ipad work fine, both under shuffle and next-advance mode.<br/><br/>My iPhone 5 has the exact same problem (and it's only about one month old). In shuffle mode, with the "shake to shuffle" off and just the "x" selected, if I try to skip ahead one song, it skips three or four songs and then just stops randomly at whichever song it wants to. This needs to be fixed. Very annoying | Níl sé ag feidhmiú mar a dhéanann suaitheadh gnáth. próiseas sé tríd an amhrán, ach ní ghabháil le amhrán tar éis a thosaíonn an Suaitheadh Chomh maith leis sin, má brúigh mé amhrán a imirt gan Suaitheadh, flashes sé an t-amhrán, ansin téann ar ais go dtí an playlist.<br/><br/>Na hamhráin chéanna ar mo macbook agus ipad oibre fíneáil, idir faoi shuffle agus an modh seo chugainn-chun cinn.<br/><br/>Tá an fhadhb chéanna ag mo iPhone 5 (agus níl ann ach thart ar mhí d'aois). I modh shuffle, leis an "shake a Suaitheadh" as agus díreach an "x" roghnaithe, má tá mé iarracht a skip ceann amháin ar aghaidh amhrán, skips sé trí nó ceithre amhrán agus ansin stop a chur go randamach ag cibé amhrán is mian sé. |
